abrdn UK Smaller Companies Growth Trust plc (AUSC) Fair Value & Analysis
Financial Services · GB · Market cap 231M GBX
Fair value as of: Jun 26, 2026
Analysis
abrdn UK Smaller Companies Growth Trust plc (AUSC) currently trades at p5.01, while our model-based Fair Value estimate is p6.24 — implying the stock looks roughly 24.6% undervalued today. We read business quality at 95/100 (high quality), in the Financial Services sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.
About the company
abrdn UK Smaller Companies Growth Trust plc is a closed-ended equity mutual fund launched by Standard Life Investments Limited. The fund is managed by Standard Life Investments (Corporate Funds) Limited. It invests in the public equity markets of the United Kingdom. The fund seeks to invest in stocks of companies operating across diversified sectors. It primarily invests in stocks of mid and small-cap companies. The fund benchmarks the performance of its portfolio against the Numis Smaller Companies Index (excluding Investment Companies). It is actively managed. The fund was formerly known as Standard Life UK Smaller Companies Trust plc. abrdn UK Smaller Companies Growth Trust plc was formed on July 9, 1993 and is domiciled in the United Kingdom.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is abrdn UK Smaller Companies Growth Trust plc (AUSC) undervalued?
What is the fair value of AUSC?
What is the quality score of AUSC?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.